Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-112,926
Closed -$822K 4421
2026
Q1
$822K Buy
+112,926
New +$1.02M ﹤0.01% 2877
2025
Q4
Sell
-28,064
Closed -$342K 4088
2025
Q3
$342K Buy
28,064
+11,275
+67% +$118K ﹤0.01% 2034
2025
Q2
$134K Buy
+16,789
New +$118K ﹤0.01% 2048
2024
Q2
Sell
-2,100
Closed -$29K 2281
2024
Q1
$29K Sell
2,100
-7,600
-78% -$119K ﹤0.01% 2090
2023
Q4
$188K Buy
9,700
+7,700
+385% +$142K ﹤0.01% 1819
2023
Q3
$42.4K Buy
+2,000
New +$52K ﹤0.01% 2168
2020
Q1
Sell
-20,800
Closed -$852K 990
2019
Q4
$852K Buy
+20,800
New +$849K ﹤0.01% 732
2019
Q3
Sell
-2,500
Closed -$123K 1365
2019
Q2
$123K Buy
+2,500
New +$127K ﹤0.01% 1024
2018
Q4
Sell
-156,300
Closed -$12.9M 1137
2018
Q3
$12.9M Buy
+156,300
New +$12.4M 0.05% 411
2018
Q1
Sell
-1,173
Closed -$80K 1064
2017
Q4
$80K Buy
+1,173
New +$75.9K ﹤0.01% 874

Other funds holding NUS

Steven Cohen's NUS Position: Q2 2026 in Review

Steven Cohen sold out of Nu Skin (NUS) in Q2 2026, closing a stake of 112,926 shares — an estimated $822K sold.

Steven Cohen first reported a position in NUS in Q4 2017 and held it in 10 quarters. The position peaked at $12.9M in Q3 2018. 161 funds tracked by Wall St. Rank hold NUS as of Q2 2026.

  • Steven Cohen reported no remaining Nu Skin position as of Q2 2026 after selling out during the quarter.
  • Steven Cohen sold 112,926 Nu Skin shares in Q2 2026, an estimated $822K.
  • Steven Cohen first reported a position in Nu Skin in Q4 2017 and held it in 10 quarters.
  • Steven Cohen's Nu Skin position peaked at $12.9M in Q3 2018.
  • 161 funds tracked by Wall St. Rank held Nu Skin as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.